A Stanford-led team has replaced toxic pre-transplant chemotherapy with a targeted antibody, allowing children with Fanconi anemia to receive stem cell transplants safely. The antibody, briquilimab, removes diseased stem cells without radiation, enabling nearly complete donor cell replacement. The approach also widens donor eligibility and could soon be applied to other bone marrow failure diseases.
source https://www.sciencedaily.com/releases/2025/11/251107010324.htm
HP announces world's first NEO:LED All-In-One — it's obviously gorgeous
looking, but here's why we love it
-
HP OmniStudio X 27 is the first All-In-One desktop PC to utilize the new
NEO:LED display technology. This screen type, powerful processors, and
helpful fea...
10 hours ago
Welcome to the 'The Fact Factory' friends. Its an interesting Hot Spot which brings to you amazing and little known facts from all over the world. So, sit back, take a tour around the world and enjoy the trivia.
No comments:
Post a Comment